Does screening for depressive symptoms help optimize duloxetine use in knee OA patients with moderate pain? A cost-effectiveness analysis.
Nora K LenhardJames K SullivanEric L RossShuang SongRobert R EdwardsDavid John HunterTuhina NeogiJeffrey N KatzElena LosinaPublished in: Arthritis care & research (2020)
Adding duloxetine to usual care for knee OA patients with moderate pain, regardless of depressive symptoms, is cost-effective at frequently-used WTP thresholds.